Lidia Karabon

1.7k total citations
68 papers, 1.2k citations indexed

About

Lidia Karabon is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Lidia Karabon has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 17 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Lidia Karabon's work include T-cell and B-cell Immunology (19 papers), Diabetes and associated disorders (17 papers) and Immune Cell Function and Interaction (16 papers). Lidia Karabon is often cited by papers focused on T-cell and B-cell Immunology (19 papers), Diabetes and associated disorders (17 papers) and Immune Cell Function and Interaction (16 papers). Lidia Karabon collaborates with scholars based in Poland, United Kingdom and Italy. Lidia Karabon's co-authors include Edyta Pawlak, Anna Tomkiewicz, Irena Frydecka, Andrzej Lange, Anna Jonkisz, Anna Partyka, Katarzyna Bogunia‐Kubik, Dorota Frydecka, Błażej Misiak and Andrzej Kiejna and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Lidia Karabon

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lidia Karabon Poland 22 646 372 216 198 170 68 1.2k
Katrin Bartels Germany 19 628 1.0× 384 1.0× 57 0.3× 393 2.0× 35 0.2× 31 1.1k
Russell Burgess United States 10 639 1.0× 229 0.6× 31 0.1× 154 0.8× 344 2.0× 13 1.1k
Alexandra Schnell United States 12 713 1.1× 208 0.6× 56 0.3× 329 1.7× 36 0.2× 16 1.2k
Elsebeth Staun-Ram Israel 16 553 0.9× 96 0.3× 53 0.2× 288 1.5× 37 0.2× 22 1.2k
Donna Ray United States 13 778 1.2× 131 0.4× 248 1.1× 535 2.7× 16 0.1× 17 1.4k
Davide Vacirca Italy 18 225 0.3× 244 0.7× 115 0.5× 348 1.8× 23 0.1× 45 1.1k
David Sibon France 19 433 0.7× 349 0.9× 34 0.2× 175 0.9× 22 0.1× 67 1.2k
Justin A. Spanier United States 19 542 0.8× 252 0.7× 226 1.0× 148 0.7× 46 0.3× 24 1.0k
Sarah L. Spain United Kingdom 14 395 0.6× 112 0.3× 265 1.2× 279 1.4× 47 0.3× 17 893
Shizue Tani‐ichi Japan 18 891 1.4× 262 0.7× 40 0.2× 295 1.5× 11 0.1× 37 1.4k

Countries citing papers authored by Lidia Karabon

Since Specialization
Citations

This map shows the geographic impact of Lidia Karabon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Karabon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Karabon more than expected).

Fields of papers citing papers by Lidia Karabon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Karabon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Karabon. The network helps show where Lidia Karabon may publish in the future.

Co-authorship network of co-authors of Lidia Karabon

This figure shows the co-authorship network connecting the top 25 collaborators of Lidia Karabon. A scholar is included among the top collaborators of Lidia Karabon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidia Karabon. Lidia Karabon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tupikowski, Krzysztof, Anna Tomkiewicz, Bartosz Małkiewicz, et al.. (2023). The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis. International Journal of Molecular Sciences. 24(3). 2042–2042. 3 indexed citations
3.
Wagner, Marta, Konrad Pawełczyk, Irena Porębska, et al.. (2023). Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 149(9). 6381–6390. 6 indexed citations
4.
5.
Partyka, Anna, Andrzej Wiśniewski, Irena Porębska, et al.. (2023). The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers. Frontiers in Immunology. 13. 1006639–1006639. 5 indexed citations
6.
Wagner, Marta, Monika Jasek, & Lidia Karabon. (2021). Immune Checkpoint Molecules—Inherited Variations as Markers for Cancer Risk. Frontiers in Immunology. 11. 606721–606721. 37 indexed citations
7.
Wagner, Marta, Krzysztof Tupikowski, Monika Jasek, et al.. (2020). SNP-SNP Interaction in Genes Encoding PD-1/PD-L1 Axis as a Potential Risk Factor for Clear Cell Renal Cell Carcinoma. Cancers. 12(12). 3521–3521. 11 indexed citations
8.
Pawlak, Edyta, Lidia Karabon, Anna Pokryszko‐Dragan, et al.. (2017). PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS. Journal of Neuroimmunology. 305. 115–127. 21 indexed citations
9.
Pawlak, Edyta, Irena Frydecka, Marek Bolanowski, et al.. (2016). CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease. Endocrine. 55(1). 186–199. 23 indexed citations
10.
Partyka, Anna, Krzysztof Tupikowski, Anna Kołodziej, et al.. (2016). Association of 3′ nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population. Urologic Oncology Seminars and Original Investigations. 34(9). 419.e13–419.e19. 20 indexed citations
11.
Frydecka, Dorota, Błażej Misiak, Lidia Karabon, et al.. (2015). Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia. SHILAP Revista de lepidopterología. 6 indexed citations
12.
Karabon, Lidia, Agnieszka Karczmarczyk, Joanna Zaleska, et al.. (2015). The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia. Leukemia & lymphoma. 56(10). 2908–2913. 19 indexed citations
13.
Karabon, Lidia, Mirosław Markiewicz, Agata Kosmaczewska, et al.. (2015). Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation. Immunology Letters. 165(1). 52–59. 9 indexed citations
14.
Wagner, Marta, Maciej Sobczyński, Lidia Karabon, et al.. (2015). Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset. Journal of Neuroimmunology. 288. 79–86. 23 indexed citations
15.
Tomkiewicz, Anna, Edyta Pawlak, Olga Grzybowska‐Izydorczyk, et al.. (2013). Intronic SNP - rs9288953 Of Suppressor Molecule Btla Confers Susceptibility To B-Cell Chronic Lymphocytic Leukemia. Blood. 122(21). 5286–5286. 1 indexed citations
16.
Frydecka, Dorota, Błażej Misiak, Jan Aleksander Beszłej, et al.. (2013). Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia. Molecular Biology Reports. 40(10). 5607–5614. 40 indexed citations
17.
Karabon, Lidia, Anna Tomkiewicz, Dariusz Wołowiec, et al.. (2011). ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Karabon, Lidia, Edyta Pawlak, Anna Tomkiewicz, et al.. (2011). Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population. Pathology & Oncology Research. 18(2). 219–226. 31 indexed citations
19.
Pawlak, Edyta, Lidia Karabon, Anna Jonkisz, et al.. (2009). Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Human Immunology. 71(2). 195–200. 59 indexed citations
20.
Mazur, Grzegorz, Katarzyna Bogunia‐Kubik, Tomasz Wróbel, et al.. (2004). IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunology Letters. 96(2). 241–246. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrin Bartels Breakdown of academic impact, for papers by Russell Burgess Breakdown of academic impact, for papers by Alexandra Schnell Breakdown of academic impact, for papers by Elsebeth Staun-Ram Breakdown of academic impact, for papers by Donna Ray Breakdown of academic impact, for papers by Davide Vacirca Breakdown of academic impact, for papers by David Sibon Breakdown of academic impact, for papers by Justin A. Spanier Breakdown of academic impact, for papers by Sarah L. Spain Breakdown of academic impact, for papers by Shizue Tani‐ichi
Rankless by CCL
2026